Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry
NCT: NCT07433491 · RECRUITING
Brief Summary
Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening/night use of blue-blocking glasses/real darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.
Frequently Asked Questions
What is Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry?
Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry is a clinical trial registered under NCT07433491. Current status: RECRUITING.
What is the status of NCT07433491?
The current status of NCT07433491 (Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry) is: RECRUITING.
When did Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry start?
Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry started on 2026-03-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.